Open access · US-GOV
via ClinicalTrials.gov Clinical trial
High Dose Supplements to Reduce Homocysteine and Slow the Rate of Cognitive Decline in Alzheimer's Disease (Vitamins to Slow Alzheimer's - VITAL)
Authors not listed
National Institute on Aging (NIA) · 2003
Abstract
The purpose of this study is to determine whether reduction of homocysteine levels with high-dose folate (folic acid), B6, and B12 supplementation will slow the rate of cognitive decline in persons with Alzheimer's disease.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-07 MST
Cite this
APA
Anonymous. (2003). High Dose Supplements to Reduce Homocysteine and Slow the Rate of Cognitive Decline in Alzheimer's Disease (Vitamins to Slow Alzheimer's - VITAL). <em>National Institute on Aging (NIA)</em>. https://clinicaltrials.gov/study/NCT00056225
Vancouver
Anonymous. High Dose Supplements to Reduce Homocysteine and Slow the Rate of Cognitive Decline in Alzheimer's Disease (Vitamins to Slow Alzheimer's - VITAL). National Institute on Aging (NIA). 2003.
BibTeX
@misc{anon2003HighDo,
title = {High Dose Supplements to Reduce Homocysteine and Slow the Rate of Cognitive Decline in Alzheimer's Disease (Vitamins to Slow Alzheimer's - VITAL)},
author = {Anonymous},
journal = {National Institute on Aging (NIA)},
year = {2003},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Neurochemical Research 1995
Citation only
Neural membrane phospholipids in alzheimer disease
Florida Atlantic University 2007
Open access · US-GOV
Delaying the Progression of Driving Impairment in Individuals With Mild Alzheimer's Disease
Nature Reviews Neurology 2010
Citation only
Cognitive intervention in Alzheimer disease
University of Vermont 2005
Open access · US-GOV
Quetiapine for the Treatment of Insomnia Associated With Alzheimer's Disease
The Lancet 2021
Preprint · OA
Alzheimer's disease
Handbook of clinical neurology 2019
Citation only